Search research articles
Contact Us
Filters
Showing results (391-400 of 481) with videos related to
Page
of 49
Sort By:
American Journal of Hematology
|
May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study
Patrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Annals of Hematology
|
June 6, 2013
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma
Simone Ferrero, Luigia Monitillo, Barbara Mantoan, et al.
Hematological Oncology
|
October 11, 2022
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study
Marzia Varettoni, Silvia Zibellini, Michele Merli, et al.
Journal of Geriatric Oncology
|
July 13, 2019
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
Francesco Merli, Federica Cavallo, Flavia Salvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma
Marco Ladetto, Gloria Pagliano, Simone Ferrero, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
MYD88<sup>L265P</sup> Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
Martina Ferrante, Daniela Furlan, Silvia Zibellini, et al.
Nanoscale
|
February 10, 2022
A novel phage display based platform for exosome diversity characterization
Domenico Maisano, Selena Mimmi, Vincenzo Dattilo, et al.
The Journal of Molecular Diagnostics : JMD
|
August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR
Daniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
British Journal of Haematology
|
April 4, 2017
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up
Paola Ghione, Elisa Genuardi, Davide Rossi, et al.
Cancer Medicine
|
July 20, 2024
Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
Irene Dogliotti, Veronica Peri, Michele Clerico, et al.
Page
of 49
Search research articles
Search
Showing results (391-400 of 481) with videos related to
Sort By:
Page
of 49
American Journal of Hematology
|
May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study
Patrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Annals of Hematology
|
June 6, 2013
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma
Simone Ferrero, Luigia Monitillo, Barbara Mantoan, et al.
Hematological Oncology
|
October 11, 2022
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study
Marzia Varettoni, Silvia Zibellini, Michele Merli, et al.
Journal of Geriatric Oncology
|
July 13, 2019
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
Francesco Merli, Federica Cavallo, Flavia Salvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma
Marco Ladetto, Gloria Pagliano, Simone Ferrero, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
MYD88<sup>L265P</sup> Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
Martina Ferrante, Daniela Furlan, Silvia Zibellini, et al.
Nanoscale
|
February 10, 2022
A novel phage display based platform for exosome diversity characterization
Domenico Maisano, Selena Mimmi, Vincenzo Dattilo, et al.
The Journal of Molecular Diagnostics : JMD
|
August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR
Daniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
British Journal of Haematology
|
April 4, 2017
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up
Paola Ghione, Elisa Genuardi, Davide Rossi, et al.
Cancer Medicine
|
July 20, 2024
Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
Irene Dogliotti, Veronica Peri, Michele Clerico, et al.
Page
of 49